More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasisTop-line data from the 12-week double-blind ...

The chronic condition causes psoriasis plaques, which are raised, inflamed, and scaly patches of skin that can cause itchiness and pain. While the condition has never interfered with Goedert’s ...

Bristol Myers Squibb (BMS) has shared positive five-year results from a long-term extension (LTE) study of its oral TYK2 ...

The European Commission (EC) has approved Biocon Biologics’ Yesintek, an ustekinumab biosimilar referencing Johnson & Johnson’s Stelara, to treat multiple inflammatory diseases.

Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasis Top-line data from the 12-week double-blind trial expected by year-end 2025 Phase 1b trial designe ...

There are many misconceptions about psoriasis—and a common one is that it is triggered by bad personal hygiene. However, ...

Dr Grant said: “I recommend keeping a close eye on dry or cracked skin as it can be a telltale sign of psoriasis. Dry skin ...

One study found that pain was self-reported as a symptom in over 4 in 10 people with plaque psoriasis. For some others, the same immune system that causes plaque on your skin could instead inflame ...

How one Big Pharma ad campaign is incorporating diversity as a driving force in improving the ways drugs are marketed directly to the patients that need them.

So you may find that your psoriasis is more likely to flare and your plaques worsen when you spend ... Alcohol and key foods probably will not trigger a psoriasis flare. Though medical researchers ...